| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Center for Human Growth and Maturation at the London Center for Pediatric Endocrinology and Metabolism, Department of Obstetrics and Gynecology, University College (C.H.R.), London, United Kingdom W1T 3AA; and Program in Development and Fetal Health, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, University of Toronto (J.C.P.K.), Toronto, Canada
Address all correspondence and requests for reprints to: Dr. P. C. Hindmarsh, Center for Human Growth and Maturation, Cobbold Laboratories, Middlesex Hospital, Mortimer Street, London, United Kingdom W1T 3AA. E-mail: p.hindmarsh{at}ucl.ac.uk.
In rodents and humans there is a sexually dimorphic pattern of GH secretion that influences the serum concentration of IGF-I. Pattern differences can be identified in children, but it is not known how early this difference is established. We studied the plasma concentrations of IGF-I, IGF-II, IGF-binding protein-3 (BP-3), and GH in cord blood taken from the offspring of 1650 singleton Caucasian pregnancies born at term and related these values to birth weight, length, and head circumference. Pregnancies complicated by preterm delivery, antepartum hemorrhage, pregnancy-induced hypertension, preeclampsia, or gestational diabetes and where cigarette smoking continued were excluded, resulting in a cohort of 987. Cord plasma concentrations of IGF-I, IGF-II, and IGFBP-3 were influenced by factors influencing birth size: gestational age at delivery, mode of delivery, maternal height, and parity of the mother. Plasma GH concentrations were inversely related to the plasma concentrations of IGF-I and IGFBP-3; 10.2% of the variability in cord plasma IGF-I concentration and 2.7% for IGFBP-3 was explained by sex of the offspring and parity. None of the factors, apart from maternal height, influenced cord serum IGF-II concentrations (adjusted r2 = 1%). Sex of the baby, mode of delivery, and parity influenced cord serum GH concentrations (adjusted r2 = 2.6%). Birth weight, length, and head circumference measurements were greater in males than females (P < 0.001). Mean cord plasma concentrations of IGF-I (males, 66.4 ± 1.2 µg/liter; females, 74.5 ± 1.3 µg/liter; P < 0.001) and IGFBP-3 (males, 910 ± 13 µg/liter; females 978 ± 13 µg/liter; P < 0.001) were significantly lower in males than females. Cord plasma GH concentrations were higher in males than females (males, 30.0 ± 1.2 mU/liter; females, 26.9 ± 1.1 mU/liter; P = 0.05), but no difference was noted between the sexes for IGF-II (males, 508 ± 6 µg/liter; females, 519 ± 6 µg/liter; P = NS). After adjustment for gestational age, parity, and maternal height, cord plasma concentrations of IGF-I and IGFBP-3 along with sex explained 38.0% of the variability in birth weight, 25.0% in birth length, and 22.7% in head circumference. These data demonstrate that in a group of singleton Caucasian babies born at term, cord plasma IGF-I, IGFBP-3, and GH concentrations relate to birth size, with evidence for sexual dimorphism in the GH-IGF axis.
This work was supported by grants from the British Heart Foundation, Children Nationwide UK, and Pharmacia-Upjohn (to P.C.H.). J.C.P.K. is funded by the Program in Development and Fetal Health, Samuel Lunenfeld Institute, and Department of Obstetrics and Gynecology, Mount Sinai Hospital, University of Toronto.
Abbreviations: CV, Coefficients of variance; IGFBP-3, IGF-binding protein 3; SDS, SD score.
This article has been cited by other articles:
 |
|
 |
|
  L. Ibanez, G. Sebastiani, A. Lopez-Bermejo, M. Diaz, M. D. Gomez-Roig, and F. de Zegher Gender Specificity of Body Adiposity and Circulating Adiponectin, Visfatin, Insulin, and Insulin Growth Factor-I at Term Birth: Relation to Prenatal Growth J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2774 - 2778. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Perrin, H. Chen, D. E. Sandberg, D. Malaspina, and A. S. Brown Growth trajectory during early life and risk of adult schizophrenia The British Journal of Psychiatry, December 1, 2007; 191(6): 512 - 520. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R Verkauskiene, J Beltrand, O Claris, D Chevenne, S Deghmoun, S Dorgeret, M Alison, P Gaucherand, O Sibony, and C Levy-Marchal Impact of fetal growth restriction on body composition and hormonal status at birth in infants of small and appropriate weight for gestational age Eur. J. Endocrinol., November 1, 2007; 157(5): 605 - 612. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Troisi, N. Potischman, and R. N. Hoover Exploring the Underlying Hormonal Mechanisms of Prenatal Risk Factors for Breast Cancer: A Review and Commentary Cancer Epidemiol. Biomarkers Prev., September 1, 2007; 16(9): 1700 - 1712. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Hyatt, H. Budge, D. Walker, T. Stephenson, and M. E. Symonds Effects of maternal parity and late gestational nutrition on mRNA abundance for growth factors in the liver of postnatal sheep Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2007; 292(5): R1934 - R1942. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Saenger, P. Czernichow, I. Hughes, and E. O. Reiter Small for Gestational Age: Short Stature and Beyond Endocr. Rev., April 1, 2007; 28(2): 219 - 251. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. E. Murphy, R. Smith, W. B. Giles, and V. L. Clifton Endocrine Regulation of Human Fetal Growth: The Role of the Mother, Placenta, and Fetus Endocr. Rev., April 1, 2006; 27(2): 141 - 169. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
